| Literature DB >> 22988452 |
Lorena S Telofski1, A Peter Morello, M Catherine Mack Correa, Georgios N Stamatas.
Abstract
Infant skin is different from adult in structure, function, and composition. Despite these differences, the skin barrier is competent at birth in healthy, full-term neonates. The primary focus of this paper is on the developing skin barrier in healthy, full-term neonates and infants. Additionally, a brief discussion of the properties of the skin barrier in premature neonates and infants with abnormal skin conditions (i.e., atopic dermatitis and eczema) is included. As infant skin continues to mature through the first years of life, it is important that skin care products (e.g., cleansers and emollients) are formulated appropriately. Ideally, products that are used on infants should not interfere with skin surface pH or perturb the skin barrier. For cleansers, this can be achieved by choosing the right type of surfactant, by blending surfactants, or by blending hydrophobically-modified polymers (HMPs) with surfactants to increase product mildness. Similarly, choosing the right type of oil for emollients is important. Unlike some vegetable oils, mineral oil is more stable and is not subject to oxidation and hydrolysis. Although emollients can improve the skin barrier, more studies are needed to determine the potential long-term benefits of using emollients on healthy, full-term neonates and infants.Entities:
Year: 2012 PMID: 22988452 PMCID: PMC3439947 DOI: 10.1155/2012/198789
Source DB: PubMed Journal: Dermatol Res Pract ISSN: 1687-6113
Infant and adult skin: similarities and differences.
| Structural differences | Infant skin | Adult skin | Reference |
|---|---|---|---|
| Epidermis | |||
| Corneocytes | Smaller | Larger | [ |
| Granular cells | Smaller | Larger | [ |
| Stratum corneum and epidermis | Thinner | Thicker | [ |
| Microrelief lines | More dense | Less dense | [ |
| Depth of surface glyphics | Similar to adult | — | [ |
| Facultative pigmentation (melanin) | Less | More | [ |
| Dermis | |||
| Dermal papillae (density, size, and morphology) | More homogeneous | Less homogeneous | [ |
| Distinct papillary-to-reticular dermis transition | Absent | Present | [ |
|
| |||
| Compositional differences | |||
|
| |||
| Epidermis | |||
| Natural moisturizing factor concentration | Lower | Higher | [ |
| pH | Higher (newborn only) | Lower | [ |
| Sebum | Lower (7–12 month-old infant) | Higher | [ |
| Stratum corneum water content | Higher | Lower | [ |
| Dermis | |||
| Collagen fiber density | Lower | Higher (young adult) | [ |
|
| |||
| Functional differences | |||
|
| |||
| Rate of water absorption | Higher | Lower | [ |
| Rate of water desorption | Higher | Lower | [ |
| Skin barrier function | Competent | Competent | [ |
| Transepidermal water loss | Higher | Lower | [ |
Figure 1Infant and adult skin: stratum corneum (SC) hydration and water transport properties. The SC of infant skin (a) and adult skin (b) is hydrated (small blue spheres) under normal conditions. Infant SC is more hydrated but also loses water at higher rates than adult SC [11].
Ideal properties of appropriately formulated cleansers for neonates and infants.
| Property | Traditional cleanser | Infant cleanser |
|---|---|---|
| Surfactant systems | Amphoteric, anionic | Amphoteric, nonionic, and ethoxylated anionic |
| Micelle diameter | Smaller | Larger |
| pH | Slightly acidic to neutral pH | pH should cause minimal changes to skin surface pH |
| Estimated IL-1ra/IL-1 | Larger | Smaller |
| Preservative system | Some claim preservative-free | Product should be “microbiologically robust” |
| Fragrance (parfum/perfume) | Higher concentration level | Lower concentration level; restrictions on specific fragrance components; fragranced product clinically evaluated for irritation and sensitization potential |
| Other | — | Product should be efficacious and should be demonstrated to be well tolerated |
IL-1α: interleukin-1α, IL-1ra: interleukin-1 receptor antagonist.
Proinflammatory activity of commercially available cleansing products.
| Cleanser | IL-1 | MTT cell proliferation assay |
|---|---|---|
| Mild baby cleanser | 100.5 ± 35.0 | 99.5% |
| Sensitive skin syndet bar | 1150.1 ± 0.1 | 6.5% |
Mean (± standard deviation) IL-1α (pg/mL) released from in vitro skin tissue equivalents (EpiDerm, MatTek Corporation, Ashland, MA, USA) after exposure to various cleansing products. MTT cell proliferation (cell viability) assay data are also shown. The sensitive skin syndet bar had significantly more cell death than the mild baby cleanser, IL-1α: interleukin-1α.
Practical considerations for emollient product selection.
| Efficacy considerations |
|---|
| (i) Appropriate tests should testify to the efficacy of the product formulation |
|
|
| Safety considerations: overall |
|
|
| (i) The margin of safety for each ingredient at the concentration used in the formulation should be considered |
| (ii) Ingredients in a product can behave differently than in isolation; therefore, it is important to evaluate the full formulation for safety and |
| potential dermal effects, including irritation and sensitization |
|
|
| Safety considerations: fragrance |
|
|
| (i) The use of fragranced products for healthy neonates and infants should be supported by evidence for safety and tolerance |
| (ii) Fragrances should be compliant with the International Fragrance Association (IFRA), which is a body that helps to ensure the safety of |
| fragrance materials |
|
|
| Safety considerations: preservatives |
|
|
| (i) Products should be microbiologically robust |
| (ii) “Natural” does not always mean safer (e.g., some natural oils (eucalyptus, sage, and tea tree oils) can be toxic at certain levels) |
| (iii) Preservative ingredients can be natural or synthetic as long as their safety profile is documented; identical chemical structure means |
| identical safety profile |
|
|
| Safety considerations: labeling and packaging |
|
|
| (i) Directions for product use should communicate and educate parents on safe and appropriate use |
| (ii) Package design should help to minimize product contamination (e.g., loose top or seal could expose product to microbes) |
Figure 2Stratum corneum (SC) moisture retention following application of mineral oil emollient. In (a), transepidermal water loss (TEWL) from the SC is shown under ambient temperature, humidity, and pressure. In (b), TEWL is reduced following emollient application. Oils in the emollient create a semiocclusive layer. The reduction in water evaporation leads to greater water retention in the SC.
Emollient therapy in healthy, full-term, or premature neonates (0–4 weeks old) or infants (1–6 months old) on skin barrier function: literature review†.
| Healthy, full-term infants | |||||
|---|---|---|---|---|---|
| Study | Cohort | Treatment | Study duration | Endpoints/ | Primary outcome(s) |
| Garcia Bartels et al. [ | 64 healthy, full-term neonates (gestation ≥37 weeks aged ≤48 hours) | Body wash; body wash with emollient use after bathing; water alone, followed by emollient after bathing | 8 weeks | TEWL, SC hydration, skin surface pH, sebum, NSCS, and bacterial colonization | Wash with emollient improved skin condition; in some cases, lower TEWL and higher SC hydration were observed; no adverse events |
| Garcia Bartels et al. [ | 44 healthy, full-term infants (≥37 weeks gestation) aged 3–6 months old | Lotion was applied after a swimming lesson once weekly or no treatment | 5 weeks | TEWL, SC hydration, skin surface pH, and sebum | Reduced TEWL in both groups; site-specific differences in the treatment group were observed |
| Lowe et al. [ | 10 healthy, full-term neonates (0–4 weeks old; gestation ≥36 weeks) with a family history of allergic disease | Emollient consisting of ceramides, cholesterol, and free fatty acids at a 3 : 1 : 1 ratio and 2% petrolatum (applied once daily) | 6 weeks | TEWL, SC hydration, skin surface pH, and sebum | Emollient use reduced TEWL |
| Simpson et al. [ | 22 full-term infants (≥37 weeks gestation) considered to be at high risk for developing atopic dermatitis | Oil-in-water, petrolatum-based emollient cream | Up to 2 years | TEWL and skin capacitance | Skin barrier measurements remained within normal range; only three participants developed atopic dermatitis |
| Premature Infants | |||||
| Beeram et al. [ | 54 infants (≤27 weeks gestation) | Petrolatum-based emollient applied every 6 hours or no treatment | 2 weeks | Fluids, electrolytes, bilirubin, and sepsis | The petrolatum-based emollient led to a significant reduction in the need for fluids; it also led to better urine output, more stable electrolytes, and lower bilirubin values |
| Brandon et al. [ | 69 infants (<33 weeks gestation) | Polymer, liquid-based film (applied twice) or petrolatum-based emollient (twice-daily application) | 2 weeks | Total fluid intake, TEWL, and neonatal skin condition | Both treatments were well tolerated; both led to a decrease in TEWL |
| Darmstadt et al. [ | 497 premature infants (≤72 hours old; gestation ≤33 weeks) | Sunflower seed oil or petrolatum-based emollient (3 times daily for 14 days, then twice daily until hospital discharge) or no treatment | ≥14 days | Survival rate and rate of nosocomial infection | Sunflower seed oil and petrolatum-based emollient reduced mortality by 25–30%; sunflower seed oil reduced nosocomial infection rates by a statistically significant margin |
| Lane and Drost [ | 34 neonates (29–36 weeks gestation) | Twice-daily application of a water-in-oil emollient; no treatment | 16 days | TEWL, NSCS, and quantitative microbiology | Emollient decreased dermatitis of the hands (days 2–11), feet (days 2–16), and abdomen (days 7–11); no changes in microbial flora |
| Nopper et al. [ | 60 neonates (<33 weeks gestation) | Petrolatum-based emollient (applied twice daily); no treatment | 2 weeks | Temperature, TEWL, fluid intake, weight analysis, skin condition, microbiology, and blood/urine analysis for cerebrospinal fluid cultures | Emollient use led to statistically significant decrease in TEWL; significant improvement in infant skin condition on days 7 and 14; less colonization of the axilla on days 2, 3, 4, and 14; statistically significant reduction of positive findings in blood and cerebrospinal fluid |
TEWL: transepidermal water loss, SC: stratum corneum, NSCS: neonatal skin condition score.
†Studies published between 1 January 1960 and 1 June 2012 were identified by searching peer-reviewed literature indexed in PubMed. The titles and abstracts of indexed publications listed in PubMed were searched using the following words: “newborn OR neonat* OR infant*” (group 1), “emollient OR lotion OR cream OR topical” (group 2), and “skin” (group 3). These three groupings were connected using the Boolean operators “AND”. The titles and abstracts were also searched using the word “vitro” and the Boolean operator “NOT”. Finally, only the titles of PubMed-indexed publications were searched using a fifth group of words and were connected to the search string using the Boolean operator “NOT”: “injury OR wound OR burn OR damage OR eczema OR dermatitis OR psoriasis OR disease* OR pain OR hemangioma* OR syndrome OR sepsis OR antisepsis.” Review articles, publications that were printed in a language other than English were also excluded. Although our search generated 220 publications, only 9 (summarized in Table 5) met the search criteria described above.